GlassScriptPhysician profile
Priscilla Maranon
NPI 1013616390
$1,631.26
in general payments reported to CMS, 2019-2025
18 companies · $1,250 in 2025
The $1,250 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $46.67 · 2024: $335 · 2025: $1,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $285.65 | 2024-2025 | Farxiga |
| Novo Nordisk INC | $241.74 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $187.46 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $154.57 | 2025 | Voquezna |
| Amgen INC. | $112.51 | 2024-2025 | Repatha, Otezla, Otezla |
| Genzyme Corporation | $105.10 | 2025 | |
| Sanofi-Aventis U.S. LLC | $103.83 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.14 | 2024-2025 | Jardiance |
| Medtronic, INC. | $94.83 | 2025 | Minimed 780g |
| Exact Sciences Corporation | $55.48 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Indivior INC. | $35.86 | 2023-2025 | Sublocade |
| Lilly USA, LLC | $32.77 | 2023-2025 | Mounjaro, Zepbound |
| Xeris Pharmaceuticals, INC. | $31.67 | 2023-2025 | Gvoke Hypopen |
| Insulet Corporation | $28.36 | 2025 | Omnipod |
| Shield Therapeutics INC | $18.92 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $15.81 | 2025 | |
| Abbvie INC. | $15.23 | 2024 | |
| Amphastar Pharmaceuticals, INC. | $14.33 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscilla Maranon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.